grantGrants.gov

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Organization National Institutes of HealthPosted 6 Dec 2024Deadline 2 Jun 2026
HHS-NIH1193.350synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: RFA-TR-25-002 Document Type: synopsis CFDA Numbers: 93.350

Read the full description

Sign up freeFree account · No credit card required
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) — National Institutes of Health | Dev Procure